Bethanie Mattek-Sands

Center for Contemporary Sciences Launches the SPARK Pledge to Modernize Safety and Toxicity Testing

Retrieved on: 
星期二, 三月 28, 2023
Partnership, European Parliament, European, Pledge, Toxicity, Research, Household, Bethanie Mattek-Sands, Organization, Corteva, Animal, United States Environmental Protection Agency, SPARK, Wyss Institute, Lush, CCS, Health, FDA, Therapy, Wyss Institute for Biologically Inspired Engineering, Pharmaceutical industry

GAITHERSBURG, Md., March 28, 2023 /PRNewswire/ -- Center for Contemporary Sciences (CCS) announces a new pledge campaign to advance human health and environmental protection.

Key Points: 
  • GAITHERSBURG, Md., March 28, 2023 /PRNewswire/ -- Center for Contemporary Sciences (CCS) announces a new pledge campaign to advance human health and environmental protection.
  • The SPARK Pledge is a commitment by industry and scientific entities to replace the use of ineffective and harmful animal experimentation in toxicity and safety testing with modern, more effective solutions.
  • "The Lush Prize welcomes the launch of the SPARK pledge led by the Center for Contemporary Sciences and is very pleased to co-sponsor the initiative.
  • "MatTek joined the SPARK Pledge because our core value is modernizing safety testing with advanced science, and we believe that the future of human health depends on it."

Volunteer Botanicals’ Satival Cannabinoid Powders Demonstrate Potential in Clinical Study

Retrieved on: 
星期二, 一月 10, 2023
Vanderbilt University Medical Center, Gene expression, Cell, Vitamin, Endothelium, Fibroblast, Cannabinoid, Sleep, Insomnia, 3D, Bethanie Mattek-Sands, Gene, Fish protein powder, Immune system, Research, Wound healing, Inflammation, Pain management, Pain, Dietary supplement

Directed by Vanderbilt University Medical Center-trained Dr. Jacob H. Basham, the study concluded that the Satival plant-based powders demonstrated a significant increase in activation within these key genes, supporting the overwhelming feedback received from consumers.

Key Points: 
  • Directed by Vanderbilt University Medical Center-trained Dr. Jacob H. Basham, the study concluded that the Satival plant-based powders demonstrated a significant increase in activation within these key genes, supporting the overwhelming feedback received from consumers.
  • “This study shows without question that no longer is there just anecdotal reports of Satival powders generating a biological effect,” said Derek Odette, chief executive officer at Volunteer Botanicals.
  • Developed by Volunteer Botanicals, Satival pharmaceutical-grade powder supplement ingredients are available for the nutraceutical market.
  • “Further research needs to be conducted on the impacts of cannabinoids, but the results of this study show that plant-based supplements are headed in the right direction,” Odette said.

Center for Contemporary Sciences (CCS) Applauds Congress for Passing the FDA Modernization Act that Will Save Millions of Lives.

Retrieved on: 
星期五, 十二月 23, 2022
Human, Death, Harvard University, FFDCA, Patient, Federal Food, Drug, and Cosmetic Act, Entrepreneurship, Drug discovery, Wyss Institute for Biologically Inspired Engineering, Liver, Health, Drug development, Biology, FDA, Safety, Animal, CCS, MPH, Multimedia, Congress, Wyss Institute, Pharmaceutical industry, Bethanie Mattek-Sands, MD

WASHINGTON, Dec. 23, 2022 /PRNewswire/ -- In a significant step for the advancement of human health, Congress passed the FDA Modernization Act as part of the FY2023 Omnibus Appropriations Bill.

Key Points: 
  • WASHINGTON, Dec. 23, 2022 /PRNewswire/ -- In a significant step for the advancement of human health, Congress passed the FDA Modernization Act as part of the FY2023 Omnibus Appropriations Bill.
  • In Section 3209 titled "Animal Testing Alternatives," the bill amends the regulatory guidance at the FDA that requires animal testing for drugs and biosimilars.
  • A recent, comprehensive study shows the superiority of Liver-Chips in predicting drug liver toxicity in humans, as compared to animal testing.
  • Center for Contemporary Sciences (CCS) is pioneering a paradigm shift towards innovative, evidence-based research methods that are based on human biology.

The Center for Contemporary Sciences Applauds House members for hearing on FDA Modernization Act of 2021.

Retrieved on: 
星期四, 三月 24, 2022
Hearing, CCS, Senate, Drug development, Bethanie Mattek-Sands, Human, Federal Food, Drug, and Cosmetic Act, Multimedia, Legislation, Patient, University of North Carolina at Pembroke, Wyss Institute for Biologically Inspired Engineering, Doctor of Philosophy, United States House Energy Subcommittee on Health, Medicine, House, Harvard University, MD, Assam Global Investors' Summit, FFDCA, Biology, Food and Drug Administration Modernization Act of 1997, FDA, Wyss Institute, University, Chapel Hill, Medical device, Pharmaceutical industry

The FDA Modernization Act of 2021 is a key legislation designed to modernize drug development.

Key Points: 
  • The FDA Modernization Act of 2021 is a key legislation designed to modernize drug development.
  • But major developments have been made since 1938 in creating effective test methods that are based on human biology.
  • The FDA Modernization Act of 2021 amends the FFDCA by broadening options for drug development to include modern, innovative, human-relevant test methods.
  • "This hearing is a key step in the right direction," said Dr. Zaher Nahle, Chief Science Officer at CCS.

Center for Contemporary Sciences (CCS) Partners with Beyond Animal to Host Investor Summit to Replace Animal Experiments.

Retrieved on: 
星期二, 三月 22, 2022
CCS, Drug development, Public policy, Regenerative medicine, Bethanie Mattek-Sands, Trailblazer, Investment, Summit, Research, MPA, Animal, Pharmaceutical industry

and MONTREUX, Switzerland, March 22, 2022 /PRNewswire/ --The March 24 Summit is the premiere event focused on driving investment into testing methods that replace animal testing and that are more human-relevant.

Key Points: 
  • and MONTREUX, Switzerland, March 22, 2022 /PRNewswire/ --The March 24 Summit is the premiere event focused on driving investment into testing methods that replace animal testing and that are more human-relevant.
  • The three-hour-event is open to the public and brings together an international group of innovators, investors, researchers, start-ups, and venture philanthropists.
  • The goal of the summit is to further the engagement among scientists, investors, and the business community, specifically in the fields of human-relevant alternatives to animal experimentation.
  • To learn more about the summit and participate, register for free at Beyond Animal.

Bethanie Mattek-Sands To Champion Kimo Sabe Mezcal

Retrieved on: 
星期三, 八月 29, 2018
Mexican cuisine, Insects as food, Distilled drinks, Mezcal, Kimo, Agave, Bethanie Mattek-Sands, Food and drink, Tennis

PASADENA, Calif., Aug. 29, 2018 /PRNewswire/ --Bethanie Mattek-Sands, "America'sTennis Rockstar,"signeda multi-year deal to become a celebrity spokesperson and brand ambassador for Kimo Sabe Mezcal,announced today by Ashley WalshKvamme,CMOand co-founder of Kimo Sabe.

Key Points: 
  • PASADENA, Calif., Aug. 29, 2018 /PRNewswire/ --Bethanie Mattek-Sands, "America'sTennis Rockstar,"signeda multi-year deal to become a celebrity spokesperson and brand ambassador for Kimo Sabe Mezcal,announced today by Ashley WalshKvamme,CMOand co-founder of Kimo Sabe.
  • Mattek-Sands will make publicappearances as well as appear in digital and print advertising for Kimo Sabe Mezcal.
  • "Kimo Sabe is a Gold Medal winning, female forward company and that is exactlywhat attracted us to Bethanie.
  • Kimo Sabe is revolutionizing the Mezcal marketthrough their unique distillation process and leading the industry with a spotlighton agave sustainability."